Giroux B - Search Results

1

[Neonatal detection of central hypothyroidism].

Giroux B, Metz C, Giroux JD, de Parscau L. Giroux B, et al. Among authors: giroux jd. Arch Pediatr. 1997 Jun;4(6):542-6. doi: 10.1016/s0929-693x(97)87576-8. Arch Pediatr. 1997. PMID: 9239270 French.

2

[Hypophyseal central hypothyroidism due to isolated TSH deficiency. Apropos of a familial neonatal case].

Giroux B, Metz C, Giroux JD, de Parscau L. Giroux B, et al. Among authors: giroux jd. Arch Pediatr. 1997 Nov;4(11):1146-8. doi: 10.1016/s0929-693x(97)88990-7. Arch Pediatr. 1997. PMID: 9488755 French. No abstract available.

3

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.

Pivot X, Awada A, Gedouin D, Kerger J, Rolland F, Cupissol D, Caponigro F, Comella G, Lopez-Pousa JJ, Guardiola E, Giroux B, Gérard B, Schneider M. Pivot X, et al. Among authors: giroux b. Ann Oncol. 2003 Mar;14(3):373-7. doi: 10.1093/annonc/mdg114. Ann Oncol. 2003. PMID: 12598340 Free article. Clinical Trial.

4

Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

Pivot X, Chamorey E, Guardiola E, Magné N, Thyss A, Otto J, Giroux B, Mouri Z, Schneider M, Milano G. Pivot X, et al. Among authors: giroux b. Ann Oncol. 2003 Oct;14(10):1578-86. doi: 10.1093/annonc/mdg410. Ann Oncol. 2003. PMID: 14504061 Free article. Clinical Trial.

5

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.

Awada A, Giacchetti S, Gerard B, Eftekhary P, Lucas C, De Valeriola D, Poullain MG, Soudon J, Dosquet C, Brillanceau MH, Giroux B, Marty M, Bleiberg H, Calvo F, Piccart M. Awada A, et al. Among authors: giroux b. Ann Oncol. 2002 Dec;13(12):1925-34. doi: 10.1093/annonc/mdf321. Ann Oncol. 2002. PMID: 12453862 Free article. Clinical Trial.

6

Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial.

Stupp R, Bauer J, Pagani O, Gerard B, Cerny T, Sessa C, Bastian G, Sarkany M, Schläpfer J, Giroux B, Leyvraz S. Stupp R, et al. Among authors: giroux b. Ann Oncol. 1998 Nov;9(11):1233-42. doi: 10.1023/a:1008495919071. Ann Oncol. 1998. PMID: 9862055 Free article. Clinical Trial.

7

Fotemustine in the treatment of brain primary tumors and metastases.

Khayat D, Giroux B, Berille J, Cour V, Gerard B, Sarkany M, Bertrand P, Bizzari JP. Khayat D, et al. Among authors: giroux b. Cancer Invest. 1994;12(4):414-20. doi: 10.3109/07357909409038234. Cancer Invest. 1994. PMID: 8032964 Review.

8

Phase II study of fotemustine in recurrent supratentorial malignant gliomas.

Frenay M, Giroux B, Khoury S, Derlon JM, Namer M. Frenay M, et al. Among authors: giroux b. Eur J Cancer. 1991;27(7):852-6. doi: 10.1016/0277-5379(91)90133-x. Eur J Cancer. 1991. PMID: 1834116

9

Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer.

Adenis A, Pion JM, Fumoleau P, Pouillart P, Marty M, Giroux B, Bonneterre J. Adenis A, et al. Among authors: giroux b. Cancer Chemother Pharmacol. 1995;35(6):527-8. doi: 10.1007/BF00686839. Cancer Chemother Pharmacol. 1995. PMID: 7882462 Clinical Trial.

10

Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity.

Boiardi A, Silvani A, Ciusani E, Watson A, Margison G, Berger E, Lucas C, Giroux B. Boiardi A, et al. Among authors: giroux b. J Neurooncol. 2001 Apr;52(2):149-56. doi: 10.1023/a:1010626421709. J Neurooncol. 2001. PMID: 11508814 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page